Unichem Laboratories Ltd

UNICHEMLAB NSE Healthcare Pharmaceuticals
₹543.60
+2.05%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.18.
  • Comfortable interest cover: operating profit covers interest about 5.9 times.
  • Net profit margin is 11.5%.
  • Profit has compounded about 25% a year over five years.
  • Sales have compounded about 12% a year over five years.
  • Promoters hold a majority stake (70.22%).

!Watch-points

  • Return on equity is on the lower side at 3.2%.
  • Return on capital employed is on the lower side at 4.1%.
  • Recent profit growth (-2%) is slower than the five-year pace (25%).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.4

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreModerate
4 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 3,827 Cr
Current Price₹ 543.60
High / Low₹ 687.20 / 278.20
Stock P/E12.5746
Book Value₹ 386.00
Dividend Yield0%
ROCE4.13%
ROE3.17%
Face Value₹ 2.00
Debt to Equity0.18
PEG Ratio0.89
EV / EBITDA13.69
Industry PE35.70
P/B Ratio1.4080311
EPS₹ 35.91
Debt₹ 500 Cr
PAT Margin11.49%
Cash PAT₹ 378 Cr
ICR5.91
Promoter Holding70.22%
FII Holding0.90%
DII Holding10.46%
Public Holding18.41%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years 5.00%
5 Years 12.00%
3 Years 18.00%
TTM 7.00%
Compounded Profit Growth
10 Years -3.00%
5 Years 25.00%
3 Years 35.00%
TTM -2.00%
Stock Price CAGR
10 Years 8.00%
5 Years 14.00%
3 Years 10.00%
1 Year 7.00%
Return on Equity
10 Years 11.00%
5 Years 0.00%
3 Years 2.00%
Last Year 3.00%
Educational data only. Not a recommendation to buy, sell or hold any security.